^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    SB225002

    i
    Other names: SB225002, SB 225002

    Associations

    News
    Twitter
    Trials
    Company:
    GSK
    Drug class:
    CXCR2 antagonist
    Related drugs:

    Associations

    News
    Twitter
    Trials